Dashboard
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 3.57% and Operating profit at 5.19% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 7.07% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of 3.57% and Operating profit at 5.19% over the last 5 years
The company has declared Positive results for the last 6 consecutive quarters
With ROCE of 10.31%, it has a very attractive valuation with a 1.01 Enterprise value to Capital Employed
Stock DNA
Specialty Chemicals
JPY 63,037 Million (Small Cap)
10.00
NA
0.02%
0.34
11.41%
1.62
Total Returns (Price + Dividend) 
DKS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

DKS Co., Ltd. Hits Day High with 13.18% Surge in Stock Price
DKS Co., a small-cap specialty chemicals firm, has experienced notable stock performance, with significant gains over various timeframes. The company boasts a market capitalization of JPY 63,037 million and a competitive P/E ratio of 10.00, although it faces challenges related to debt and modest growth rates.
Read More
DKS Co. Hits Day Low of JPY 5,660 Amid Price Pressure
DKS Co., Ltd., a small-cap specialty chemicals firm, saw its stock decline significantly today, contrasting with the broader market. Despite a strong annual performance, the company has faced short-term challenges. Financial metrics indicate moderate leverage and profitability, but net sales growth has been modest over the past five years.
Read More
DKS Co. Hits Day High with 8.22% Surge in Strong Intraday Performance
DKS Co., a small-cap specialty chemicals company, has experienced significant growth, with a year-to-date increase of 65.01% and a remarkable 96.88% rise over the past year. The company maintains a low debt-to-equity ratio and a return on equity of 11.41%, reflecting strong financial health.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2011
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 1 Foreign Institutions (0.03%)
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
QoQ Growth in quarter ended Mar 2025 is 0.76% vs 5.25% in Dec 2024
QoQ Growth in quarter ended Mar 2025 is 7.45% vs -6.75% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 16.06% vs -3.02% in Mar 2024
YoY Growth in year ended Mar 2025 is 132.64% vs 3,451.02% in Mar 2024






